R&D Trends

Report of flat R&D pipeline: good news amid economic woes or sign of more turmoil ahead?

Tuesday, July 5, 2011 08:02 AM

The research and development pipeline has officially flattened out.

More... »

Jubilant, Janssen collaborate on neuroscience development

Thursday, June 30, 2011 01:28 PM

A Jubilant Life Sciences subsidiary has formed an alliance to deliver pre-clinical candidates in the neuroscience field to Belgium’s Janssen Pharmaceutica, according to PharmaTimes.

More... »

CEO says Eli Lilly is committed to R&D

Thursday, June 30, 2011 01:14 PM

Eli Lilly is committed to spending what it takes to come up with innovative drugs over the long term, its chief executive said, even though the company's earnings are expected to tumble over the next three years.

More... »

AZ, PTC collaborate in oncology

Thursday, June 30, 2011 09:59 AM

AstraZeneca and PTC Therapeutics are joining forces for cancer cures, using PTC's discovery/development technology platform, reported FierceBiotech.  AZ will front an undisclosed amount of cash to work on the first oncology target.

More... »

UCB launches research alliance with Harvard University

Wednesday, June 29, 2011 12:22 PM

Brussels-based UCB and Harvard University have officially launched an innovative research alliance in a signing ceremony in Boston attended by his Royal Highness Prince Philippe of Belgium.

More... »

Triple alliance forged to create end-to-end therapeutic discovery platform

Wednesday, June 29, 2011 12:14 PM

Three U.K.-based biotech companies, Isogenica, Biolauncher and Cresset Biomolecular Discovery, have formed a collaborative joint venture, according to the U.K.’s Business Weekly.

More... »

Nations join UN protocol on sharing genetic resources

Wednesday, June 29, 2011 10:30 AM

Twelve nations and the European Union have added their signatures to a United Nations treaty on the equitable sharing of the planet’s genetic resources.

More... »

Nimbus raises $24 million to launch new biotech model

Tuesday, June 28, 2011 02:41 PM

A Cambridge, Mass.-based biotech startup with big plans for computational drug discovery work has lined up a $24 million financing round with the help of some high-profile investors, including Microsoft's billionaire chairman Bill Gates, according to FierceBiotech.

More... »

Report: Biomarkers market will hit $19.86 billion in 2015

Tuesday, June 28, 2011 02:39 PM

A new report from visiongain, a London-based business information provider, predicts the global biomarkers market will be worth $19.86 billion in 2015.

More... »

Singapore R&D consortium aims to tap into outsourcing trend

Tuesday, June 28, 2011 02:32 PM

Government agency International Enterprise (IE) Singapore has launched a biomedical R&D consortium involving seven companies based in the island state, with the aim of tapping into the trend for outsourcing of R&D across Asia, according to PharmaTimes.

More... »